Different Patterns of Vascular Response Between Patients With or Without Diabetes Mellitus After Drug-Eluting Stent Implantation Optical Coherence Tomographic Analysis

被引:36
作者
Tanaka, Nobuyoshi [1 ]
Terashima, Mitsuyasu [1 ]
Rathore, Sudhir [1 ]
Itoh, Tsuyoshi [1 ]
Habara, Maoto [1 ]
Nasu, Kenya [1 ]
Kimura, Masashi [1 ]
Itoh, Tatsuya [1 ]
Kinoshita, Yoshihisa [1 ]
Ehara, Mariko [1 ]
Tsuchikane, Etsuo [1 ]
Asakura, Keiko [1 ]
Asakura, Yasushi [1 ]
Katoh, Osamu [1 ]
Suzuki, Takahiko [1 ]
机构
[1] Toyohashi Heart Ctr, Dept Cardiol, Toyohashi, Aichi 4418530, Japan
关键词
diabetes mellitus; optical coherence tomography; sirolimus-eluting stent(s); vascular response; BARE-METAL STENTS; CORONARY-ARTERY; FOLLOW-UP; RESTENOSIS; THROMBOSIS; PREDICTORS; ULTRASOUND; RAPAMYCIN; REGISTRY; RISK;
D O I
10.1016/j.jcin.2010.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We performed this study to investigate with optical coherence tomography (OCT) the vascular response after sirolimus-eluting stent (SES) implantation between patients with and those without diabetes mellitus (DM). Background The difference in vascular response after SES implantation between patients with and those without DM has not been fully evaluated with OCT. Methods Optical coherence tomography was performed to examine 74 nonrestenotic SES implanted in 63 patients (32 with DM and 31 without DM) at 9 months after SES implantation. For struts showing neointimal coverage, the neointimal thickness on the luminal side of each strut section was measured, and neointimal characteristics were classified into high, low, and layered signal pattern. Results Baseline patient characteristics and lesion and procedural characteristics data were similar between the 2 groups. In total, 11,422 struts were analyzed. High signal neointima was observed in 90.2 +/- 13.9%, low signal neointima in 7.3 +/- 10.0%, and layered neointima in 2.7 +/- 5.8%/stents. There was higher incidence of low signal neointima (10.5 +/- 10.3% vs. 4.5 +/- 5.6%, p = 0.003), neointimal thickness was larger (median: 106.8 mu m, interquartile range: 79.3 to 130.4 mu m vs. median: 83.5 mu m, interquartile range: 62.3 to 89.3 mu m; p < 0.0001), and neointimal coverage of stent struts was higher (92.1 +/- 6.2% vs. 87.2 +/- 11.9%; p = 0.03) in DM patients. Conclusions High signal neointimal pattern was predominantly observed, and low or layered signal pattern was observed in some cases. In DM patients, low signal neointima was observed with high frequency. Neointimal coverage and neointimal thickness was also higher in DM patients as compared with non-DM patients. (J Am Coll Cardiol Intv 2010;3:1074-9) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1074 / 1079
页数:6
相关论文
共 19 条
[1]  
ARANSON D, 1996, J AM COLL CARDIOL, V27, P528
[2]   Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus A Report From the SCAAR (Swedish Angiography and Angioplasty Registry) [J].
Frobert, Ole ;
Lagerqvist, Bo ;
Carlsson, Jorg ;
Lindback, Johan ;
Stenestrand, Ulf ;
James, Stefan K. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (18) :1660-1667
[3]   Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents [J].
Iakovou, I ;
Schmidt, T ;
Bonizzoni, E ;
Ge, L ;
Sangiorgi, GM ;
Stankovic, G ;
Airoldi, F ;
Chieffo, A ;
Montorfano, M ;
Carlino, M ;
Michev, I ;
Corvaja, N ;
Briguori, C ;
Gerckens, U ;
Grube, E ;
Colombo, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2126-2130
[4]   Stent thrombosis after successful sirolimus-eluting stent implantation [J].
Jeremias, A ;
Sylvia, B ;
Bridges, J ;
Kirtane, AJ ;
Bigelow, B ;
Pinto, DS ;
Ho, KKL ;
Cohen, DJ ;
Garcia, LA ;
Cutlip, DE ;
Carrozza, JP .
CIRCULATION, 2004, 109 (16) :1930-1932
[5]   Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients -: Three-dimensional ultrasound results of the diabetes and sirolimus-eluting stent (DIABETES) trial [J].
Jimenez-Quevedo, Pilar ;
Sabate, Manel ;
Angiolillo, Dominick J. ;
Costa, Marco A. ;
Alfonso, Fernando ;
Gomez-Hospital, Joan Antoni ;
Hernandez-Antolin, Rosana ;
Banuelos, Camino ;
Goicolea, Javier ;
Fernandez-Aviles, Francisco ;
Bass, Theodore ;
Escaned, Javier ;
Moreno, Raul ;
Fernandez, Cristina ;
Macaya, Carlos .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (11) :2172-2179
[6]   Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk [J].
Joner, Michael ;
Finn, Aloke V. ;
Farb, Andrew ;
Mont, Erik K. ;
Kolodgie, Frank D. ;
Ladich, Elena ;
Kutys, Robert ;
Skorija, Kristi ;
Gold, Herman K. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :193-202
[7]  
KANAZAKI T, 1994, EUR J CLIN INVEST, V24, P377
[8]   Delayed Neointimalization on Sirolimus-Eluting Stents-6-Month and 12-Month Follow up by Optical Coherence Tomography [J].
Katoh, Hiroki ;
Shite, Junya ;
Shinke, Toshiro ;
Matsumoto, Daisuke ;
Tanino, Yusuke ;
Ogasawara, Daisuke ;
Sawada, Takahiro ;
Miyoshi, Naoki ;
Kawamori, Hiroyuki ;
Yoshino, Naoki ;
Hirata, Ken-ichi .
CIRCULATION JOURNAL, 2009, 73 (06) :1033-1037
[9]   ADVANCED PROTEIN GLYCOSYLATION INDUCES TRANSENDOTHELIAL HUMAN MONOCYTE CHEMOTAXIS AND SECRETION OF PLATELET-DERIVED GROWTH-FACTOR - ROLE IN VASCULAR-DISEASE OF DIABETES AND AGING [J].
KIRSTEIN, M ;
BRETT, J ;
RADOFF, S ;
OGAWA, S ;
STERN, D ;
VLASSARA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :9010-9014
[10]  
Kornowski R, 1997, CIRCULATION, V95, P1366